This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Park, S. Articles by Habib, A. A. Search for Related Content PubMed PubMed Citation Articles by Park, S. Articles by Habib, A. A.

The Receptor Interacting Protein 1 Inhibits p53 Induction through NF-B Activation and Confers a Worse Prognosis in Glioblastoma

Departments of ¹ Neurology, ² Pathology, ³ Clinical Sciences, ⁴ Neurosurgery, ⁵ Radiation Oncology, and ⁶ Radiology, ⁷ Annette G. Strauss Center of Neurooncology, and ⁸ Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas and ⁹ Department of Neurological Surgery, University of California-San Francisco, San Francisco, California

Requests for reprints: Amyn A. Habib, University of Texas Southwestern Medical Center, Mail Code 8813, 6001 Forest Park ND4.136, Dallas, TX 75390-8813. Phone: 214-645-6237; Fax: 214-645-6240; E-mail: Amyn.Habib{at}UTSouthwestern.edu.

Key Words: inflammation • cancer • p53 • RIP1 • NF-B • prognosis • glioblastoma

Nuclear factor-B (NF-B) activation may play an important role in the pathogenesis of cancer and also in resistance to treatment. Inactivation of the p53 tumor suppressor is a key component of the multistep evolution of most cancers. Links between the NF-B and p53 pathways are under intense investigation. In this study, we show that the receptor interacting protein 1 (RIP1), a central component of the NF-B signaling network, negatively regulates p53 tumor suppressor signaling. Loss of RIP1 from cells results in augmented induction of p53 in response to DNA damage, whereas increased RIP1 level leads to a complete shutdown of DNA damage–induced p53 induction by enhancing levels of cellular mdm2. The key signal generated by RIP1 to up-regulate mdm2 and inhibit p53 is activation of NF-B. The clinical implication of this finding is shown in glioblastoma, the most common primary malignant brain tumor in adults. We show that RIP1 is commonly overexpressed in glioblastoma, but not in grades II and III glioma, and increased expression of RIP1 confers a worse prognosis in glioblastoma. Importantly, RIP1 levels correlate strongly with mdm2 levels in glioblastoma. Our results show a key interaction between the NF-B and p53 pathways that may have implications for the targeted treatment of glioblastoma. [Cancer Res 2009;69(7):2809–16]

This article has been cited by other articles:

				S. Park, D. Zhao, K. J. Hatanpaa, B. E. Mickey, D. Saha, D. A. Boothman, M. D. Story, E. T. Wong, S. Burma, M.-M. Georgescu, et al. RIP1 Activates PI3K-Akt via a Dual Mechanism Involving NF-{kappa}B-Mediated Inhibition of the mTOR-S6K-IRS1 Negative Feedback Loop and Down-regulation of PTEN Cancer Res., May 15, 2009; 69(10): 4107 - 4111. [Abstract] [Full Text] [PDF]